These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21394722)

  • 21. An Investigation Into Vortioxetine Salts: Crystal Structure, Thermal Stability, and Solubilization.
    He SF; Zhang XR; Zhang S; Guan S; Li J; Li S; Zhang L
    J Pharm Sci; 2016 Jul; 105(7):2123-8. PubMed ID: 27262207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel furosemide cocrystals and selection of high solubility drug forms.
    Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A
    J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs.
    David SE; Timmins P; Conway BR
    Drug Dev Ind Pharm; 2012 Jan; 38(1):93-103. PubMed ID: 22118222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting the crystallization propensity of carboxylic acid buffers in frozen systems--relevance to freeze-drying.
    Sundaramurthi P; Suryanarayanan R
    J Pharm Sci; 2011 Apr; 100(4):1288-93. PubMed ID: 24081466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clozapine-carboxylic acid plasticized co-amorphous dispersions: Preparation, characterization and solution stability evaluation.
    Ali AM; Ali AA; Maghrabi IA
    Acta Pharm; 2015 Jun; 65(2):133-46. PubMed ID: 26011930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of β-cyclodextrin on the Properties of Norfloxacin Form A.
    Chierentin L; Garnero C; Chattah AK; Delvadia P; Karnes T; Longhi MR; Salgado HR
    AAPS PharmSciTech; 2015 Jun; 16(3):683-91. PubMed ID: 25511811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
    Parikh T; Sandhu HK; Talele TT; Serajuddin AT
    Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and characterization of dicarboxylic acids salt of aripiprazole with enhanced physicochemical properties.
    Hamideh A; Rahman Z; Dharani S; Khuroo T; Mohamed EM; Nutan MTH; Reddy IK; Khan MA
    Pharm Dev Technol; 2021 Apr; 26(4):455-463. PubMed ID: 33653226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cocrystal or salt: does it really matter?
    Aakeröy CB; Fasulo ME; Desper J
    Mol Pharm; 2007; 4(3):317-22. PubMed ID: 17497799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physicochemical characterization of nedocromil bivalent metal salt hydrates. 2. Nedocromil zinc.
    Zhu H; Padden BE; Munson EJ; Grant DJ
    J Pharm Sci; 1997 Apr; 86(4):418-29. PubMed ID: 9109042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solubility behavior and biopharmaceutical classification of novel high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives.
    Breda SA; Jimenez-Kairuz AF; Manzo RH; Olivera ME
    Int J Pharm; 2009 Apr; 371(1-2):106-13. PubMed ID: 19150493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and characterization of new salts of tioconazole. Comparison of their dissolution performance.
    Moroni AB; Mayoral EP; Lionello DF; Vega DR; Kaufman TS; Calvo NL
    Int J Pharm; 2024 Mar; 652():123855. PubMed ID: 38280497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
    McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
    Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New Solid Forms of the Antiviral Drug Arbidol: Crystal Structures, Thermodynamic Stability, and Solubility.
    Surov AO; Manin AN; Churakov AV; Perlovich GL
    Mol Pharm; 2015 Nov; 12(11):4154-65. PubMed ID: 26479207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights into hydrate formation and stability of morphinanes from a combination of experimental and computational approaches.
    Braun DE; Gelbrich T; Kahlenberg V; Griesser UJ
    Mol Pharm; 2014 Sep; 11(9):3145-63. PubMed ID: 25036525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isotope-Edited Infrared Spectroscopy for Efficient Discrimination between Pharmaceutical Salts and Cocrystals.
    Iwata K; Karashima M; Ikeda Y
    Mol Pharm; 2017 Jul; 14(7):2350-2358. PubMed ID: 28502182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solid-state characterization and transformation of various creatine phosphate sodium hydrates.
    Xu Y; Jiang L; Huang Y; Wang JR; Mei X
    J Pharm Sci; 2014 Nov; 103(11):3688-3695. PubMed ID: 25223726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transformation of acidic poorly water soluble drugs into ionic liquids.
    Balk A; Wiest J; Widmer T; Galli B; Holzgrabe U; Meinel L
    Eur J Pharm Biopharm; 2015 Aug; 94():73-82. PubMed ID: 25976317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical characterization of the hydrates of urapidil.
    Botha SA; Caira MR; Guillory JK; Lötter AP
    J Pharm Sci; 1988 May; 77(5):444-51. PubMed ID: 3411469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.